Oppenheimer Maintains Outperform on enGene Holdings, Lowers Price Target to $30
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Oppenheimer analyst Leland Gershell maintains enGene Holdings (NASDAQ:ENGN) with a Outperform and lowers the price target from $33 to $30.
Oppenheimer analyst Leland Gershell maintains enGene Holdings (NASDAQ:ENGN) with a Outperform and lowers the price target from $33 to $30.